Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-800-4 | CAS number: 88-12-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Short description of key information on bioaccumulation potential result:
Absoprtion: expected to be rapid by oral and inhalation routes, slow by the dermal route
Distribution: primarily liver, kidney, and small intestine (including contents) in rats and dogs
Excretion/Elimination: rapid primarily in urine and feces in rats and dogs
Clearance from plasma: expected to be rapid
Protein binding: low in the rat and dog
Short description of key information on absorption rate:
Dermal Absorption Rate (Estimated): 0.067 mg/cm2-hr.
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
Additional information
Based on available information in SD rats and Beagle dogs, N-Vinyl-2-pyrrolidone (nVP) is expected to be rapidly absorbed following inhalation and oral exposures, and slowly following dermal exposures; is expected to distribute primarily to the liver, kidneys, and small intestine (including contents); and is expected to be excreted primarily in urine and eliminated as feces. The major metabolites have not been reliably determined.
Discussion on bioaccumulation potential result:
The absorption, disposition, and metabolism of radiolabelled 1-ethenyl-2-pyrrolidinone (N-vinyl-2-pyrrolidinone; NVP) has been studied in a series of experiments in male Sprague-Dawley rats and female beagle dogs (McClanahan, et. al., 1987; McClanahan, et. al., 1983; Digenis, G.A. et. al., 1982; Digenis, G.A. et. al., 1990; and BASF AG, 1992). From these experiments, it can be concluded that NVP is rapidly absorbed by the oral and inhalation routes and slowly by the dermal route; is distributed primarily to the liver, kidneys and small intestine (including its contents); and is excreted primarily in urine and eliminated via feces. In addition, clearance from plasma following single i.v. injections was determined to follow a biphasic/biexponential pattern in rats with a half-life of 3.8 hours and a monophasic/monoexponential pattern in dogs with a half-life of 0.3 hours. Based on urine analysis by radiomonitored reversed phase HPLC, the two major metabolites, accounting for 50% and 33% of both the 3H- and 14C-excreted activity, could not be identified but eluted at 14.0 and 52.5 min, respectively. Minor metabolites were, however, believed to include N-acetyl-gamma-amino butyric acid, 2-pyrrolidinone, and N-vinyl succinimide. Finally, NVP shows low protein binding in the rat and the dog.
Discussion on absorption rate:
Using U.S. EPA DERMWIN v1.43a, the dermal absorption rate of n-Vinylpyrrolidone (nVP) is estimated to be 0.067 mg/cm2 -hr, which equates to a permeation coefficient (Kp) of 0.000769 cm/hr (ISP, 2010). No measured data, of sufficient reliability, are available. However, the clinical observations made during acute toxicity studies via the dermal route (BASF, 1979) and measurement of low levels (near analytical detection) of nVP in blood (Beagle dods) following dermal administration (BASF, 1992) suggest that nVP can be absorbed through the skin and partition to blood though much more slowly than by inhalation and oral routes.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.